Founded in
2015
SHORT DESCRIPTION:
Biomensio – next generation multianalyte biosensing, smart, quick, and mobile. Our technology platform consists of a fully digital multianalyte sensor, fluid cartridges and a handheld reader, with a customer specific API or a cloud-based analytics service. The initial point-of-need application areas include the detection of SARS-CoV-2 and Drugs of Abuse in saliva, as well as food and milk safety. Contact us to explore our offering for your application, or if you wish to expand your diagnostics portfolio with the Biomensio technology!
LONG DESCRIPTION:
Tampere, Western Finland
2015
$ 5 Millions - $ 10 Millions
Add a review